| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-4939-0348-1_3 |
| P698 | PubMed publication ID | 24696329 |
| P50 | author | Ruklanthi de Alwis | Q46153442 |
| Aravinda M. de Silva | Q89242260 | ||
| P2093 | author name string | Ruklanthi de Alwis | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Dengue virus | Q476209 | ||
| flow cytometry | Q1141429 | ||
| P304 | page(s) | 27-39 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Measuring antibody neutralization of dengue virus (DENV) using a flow cytometry-based technique | |
| P478 | volume | 1138 |
| Q66679555 | A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice |
| Q33825684 | A human inferred germline antibody binds to an immunodominant epitope and neutralizes Zika virus |
| Q36237429 | Automatic Generation of Validated Specific Epitope Sets |
| Q39260235 | Chikungunya Virus Growth and Fluorescent Labeling: Detection of Chikungunya Virus by Immunofluorescence Assay |
| Q36700993 | Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera |
| Q38609515 | Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward |
| Q49269944 | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
| Q64980123 | Exploiting the Legacy of the Arbovirus Hunters. |
| Q92416661 | Genetic risk for dengue hemorrhagic fever and dengue fever in multiple ancestries |
| Q51336680 | Immune Responses to Dengue and Zika Viruses-Guidance for T Cell Vaccine Development. |
| Q35935142 | Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype |
| Q58758276 | Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans |
| Q29051494 | Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection |
| Q36584038 | Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing. |
| Q41924121 | Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques. |
| Q47558388 | Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. |
| Q40040450 | Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine |
| Q35221318 | Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort |
| Q90205634 | Serologic Tools and Strategies to Support Intervention Trials to Combat Zika Virus Infection and Disease |
Search more.